{
    "id": "TestCase_4",
    "name": "PTFQ_10",
    "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
    "tags": [],
    "test_runner_settings": [
        "pathfinder"
    ],
    "test_assets": [
        {
            "id": "Asset_88",
            "name": "PTFQ_10: Warfarin to Cancer Neoplasia",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 2,
            "path_nodes": [
                {
                    "ids": [
                        "NCBIGene:79001"
                    ],
                    "name": "VKORC1"
                },
                {
                    "ids": [
                        "MESH:C021527"
                    ],
                    "name": "vitamin K oxidoreductase"
                },
                {
                    "ids": [
                        "NCBIGene:558"
                    ],
                    "name": "AXL"
                },
                {
                    "ids": [
                        "NCBIGene:2621"
                    ],
                    "name": "GAS6"
                },
                {
                    "ids": [
                        "CHEBI:28384"
                    ],
                    "name": "Vitamin K"
                },
                {
                    "ids": [
                        "GO:0001837, GO:0010717"
                    ],
                    "name": "Epthelial-to-Mesenchymal -transition"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_92",
            "name": "PTFQ_10.4: Warfarin to Cancer Neoplasia, GAS6",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "NCBIGene:2621"
                    ],
                    "name": "GAS6"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_93",
            "name": "PTFQ_10.5: Warfarin to Cancer Neoplasia, Vitamin K",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "CHEBI:28384"
                    ],
                    "name": "Vitamin K"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_89",
            "name": "PTFQ_10.1: Warfarin to Cancer Neoplasia, VKORC1",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "NCBIGene:79001"
                    ],
                    "name": "VKORC1"
                },
                {
                    "ids": [
                        "MESH:C021527"
                    ],
                    "name": "vitamin K oxidoreductase"
                },
                {
                    "ids": [
                        "NCBIGene:558"
                    ],
                    "name": "AXL"
                },
                {
                    "ids": [
                        "NCBIGene:2621"
                    ],
                    "name": "GAS6"
                },
                {
                    "ids": [
                        "CHEBI:28384"
                    ],
                    "name": "Vitamin K"
                },
                {
                    "ids": [
                        "GO:0001837, GO:0010717"
                    ],
                    "name": "Epthelial-to-Mesenchymal -transition"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_94",
            "name": "PTFQ_10.6: Warfarin to Cancer Neoplasia, Epthelial-to-Mesenchymal -transition",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "GO:0001837, GO:0010717"
                    ],
                    "name": "Epthelial-to-Mesenchymal -transition"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_90",
            "name": "PTFQ_10.2: Warfarin to Cancer Neoplasia, vitamin K oxidoreductase",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "MESH:C021527"
                    ],
                    "name": "vitamin K oxidoreductase"
                }
            ],
            "expected_output": "TopAnswer"
        },
        {
            "id": "Asset_91",
            "name": "PTFQ_10.3: Warfarin to Cancer Neoplasia, AXL",
            "description": "Why do patients on Warfarin have a markedly reduced incidence of various cancers?",
            "tags": [],
            "test_runner_settings": [
                "pathfinder"
            ],
            "source_input_id": "CHEBI:10033",
            "source_input_name": "Warfarin",
            "source_input_category": "biolink:SmallMolecule",
            "target_input_id": "MONDO:0004992",
            "target_input_name": "Cancer",
            "target_input_category": "biolink:Disease",
            "predicate_id": "biolink:related_to",
            "predicate_name": "related to",
            "qualifiers": null,
            "minimum_required_path_nodes": 1,
            "path_nodes": [
                {
                    "ids": [
                        "NCBIGene:558"
                    ],
                    "name": "AXL"
                }
            ],
            "expected_output": "TopAnswer"
        }
    ],
    "test_case_objective": "AcceptanceTest",
    "components": [
        "ars"
    ],
    "test_env": "ci"
}